In This Issue 
March 2021
Welcome To Paragon Ventures
We hope this note finds you safe and well as the world continues to grapple with the challenges of a pandemic. As our businesses are all on the front lines of healthcare and life sciences we continue to be honored (and amazed) by the spirit and dedication to succeed during these trying times.

We are pleased to report that through 2020, Paragon Ventures had a record transactional year. Collectively, our clients represented over $150MM in revenues and a broad base of care initiatives. Read more about them in our transaction report below. Healthcare M&A transactions in 2020 increased substantially as reported in our Market Pulse reports.

Inside this edition, we have a healthy selection of new acquisitions opportunities across several healthcare sectors. From healthy living products to biologic therapies we have something of beauty across the continuum of care.


If the time is right for you and your business, the healthcare M&A markets are strong and some sectors offering unprecedented valuations and options for management through a strategic transaction. As always we welcome your inquires and continue to hold all discussions strictly confidential.

AVAILABLE FOR ACQUISITION
PV ID#MA321-20020
Infusion Therapy Services

Revenue: $22.6MM - EBITDA: $2.4+MM
Available for acquisition is this infusion therapy services Company providing in-suite services. This established company focuses on rheumatology and biologic infusions. With a strong reputation as a premier infusion center, they have built a diverse referral base including gastroenterology, dermatology, primary care and ophthalmology. Infusion services represents the core of their business.

Revenue for FY 2020 is up over 20% over the previous year. This growing Company operates in-suite centers in multiple locations with an impressive growth trajectory for FY 2021.



For more information, please contact Paragon Ventures
Call: 800-719-1555 Ext. 205 or 603-661-7188 (cell)


When The Time Is Right...
Paragon Ventures
AVAILABLE FOR ACQUISITION
PV ID#SE320-20015
Long Term Care Nurse Staffing

Revenue: $15.09MM - EBITDA: $2.25MM
Available for acquisition is a southeast US based nurse staffing agency with strong contract relationships in the long-term care industry. The Company provides registered nurses, licensed practical nurses, and certified nurse assistants to serve patients in long-term care facilities.

The staff includes highly trained and experienced healthcare professionals including licensed RNs, LPNs and CNAs that serve the Company's growing patient population.

The Company's reputation servicing LTC facilities provides strong margins and a sustainable EBITDA. For year end 2020, the business generated $15.08MM revenues with an adjusted EBITDA exceeding $2.25MM. The Company continues to grow with solid business and referral relationships within the long-term care industry.


For more information, 
Contact Scott Fife
Call: 800-719-1555, Ext 203 or (215) 356-8003 (mobile) 
AVAILABLE FOR ACQUISITION
PV ID#US321-08016
Skin Care: Aesthetic Device Manufacturer

Revenue: $9MM - EBITDA: $3MM
*(projected YE 2021)
Available for acquisition is this leader in the manufacturing and distribution of premier skincare products and medical aesthetic device technologies. This established company has been in business for over 15 years. The company focuses on designing and developing products that enhance the patient experience and optimize treatment results. In April of 2020, the company achieved FDA clearance for one of its major aesthetic devices. In addition, the launch of two new products in Q4 2020 and Q1 2021 are driving strong revenues and EBITDA for FY 2021.

With an expert product team, the company is committed to providing customers with the most comprehensive product knowledge, elite device training, and advanced treatment techniques for procedures such as Micro needling and PRP Therapy.
In addition to its growing business based in the United States, the company also has distribution in the UK, Ireland & South Africa. In 2021 Company revenue is expected to exceed $9MM with adjusted EBITDA over $3MM. The business is well positioned for continued growth and the expansion of its product lines and geographic coverage.

For more information, please contact Paragon Ventures

Call: 800-719-1555 Ext. 205 or 603-661-7188 (cell)


AVAILABLE FOR ACQUISITION
PV ID#MA320-15010

Hi-tech Medical Equipment Rental Company

Revenue: $6.8MM - EBITDA: $3.5MM
Available for acquisition is a business-to-business provider of medical equipment rental service to hospitals, long term care providers, respiratory rehab and home healthcare. The business is renowned for its biomedical equipment expertise and high-quality service. All equipment is provided patient ready and delivery services available 365 days 24/7. This enables its caregiver customers to focus on the clinical needs of their patients without the burden and expense of ownership and maintenance of the equipment.
The Company serves as a vital resource to its customers by offering to meet their biomedical equipment needs on an as needed basis and thus more effectively manage their scarce capital. As the healthcare industry continues to be challenged by increasing demand with declining reimbursements, providers are becoming increasingly aware that the true costs of capital equipment include more than the fixed cost of acquisition. Periodic maintenance requirements, repair costs, logistics and asset management, continue to contribute to expenses even as utilization fluctuates. The option of biomedical equipment rental turns these fixed costs into variable expense tied to actual utilization needs.

For more information contact Paragon Ventures

Jonathan Sadock
Call: 800-719-1555, Ext 201 or (610) 331-6900 (mobile) 
AVAILABLE FOR ACQUISITION
PV ID#MW314-06003
Full Line Medical Supply Distributor

Revenue: $15.5MM - EBITDA: $1.5MM
Strategically, the Company has developed many successful programs over the years to sell to healthcare professionals and consumers. They have utilized various channels such as outside and inside sales representatives, direct to consumer and health care professionals, and through on-line platforms. One distinct opportunity the company recognized was the growing use of on-line ordering.

The Company had developed different avenues through which a customer can order; such as use of ordering guides telephonically, their online store or other online platforms such as Amazon. Although consumers order through the platform company, the Company is the fulfilment center and successfully secures repeat orders as a result of their strong ratings. The Company consistently monitors its products sold through the platform channels to ensure profitability margins are maintained.

Additionally, the Company offers specialty packaged items that are exclusive. Recognizing the increase in out of pockets payments due high deductible insurance plans, the Company leveraged its buying power to offer competitive pricing to meet that market need. The Company does not currently bill third party payors which offers an opportunity for future revenue growth outside its current strategic focus.


For more information, please contact Paragon Ventures
Call: 800-719-1555 Ext. 205 or 603-661-7188 (cell)


AVAILABLE FOR ACQUISITION
PV ID#SE321-02050
Natural Health Products Manufacturer & Distributor

Revenue: $2MM - EBITDA: $900K
Available for acquisition is a Natural Products Company that designs, manufactures, and markets products that Relieve Symptoms, Fix the Ailment and Facilitate Repair. Substantial time and effort in the business model has produced significant market penetration and profit, year after year.

A new owner of this business will benefit immediately from a substantial cash flow allowing for future initiatives including new product development, market expansion, increased distribution opportunities and greater presence among end users.  Steady revenue growth with sales of $2.0mm and a healthy EBIDTA of $898k. All operational systems are in place for an easy transition to new ownership. The founder will provide transitional services including at buyer’s option, to continue to be involved in new product development, product research and clinical oversight.

For more information, 
Contact Tony Marsallo
Call: 800-719-1555, Ext 209 or (315) 559-3140 (mobile) 
AVAILABLE FOR ACQUISITION
PV ID#NE320-20706
Sleep/CPAP, Respiratory & DME Provider

Revenue: $7.1MM - EBITDA: $1.1MM
Available for acquisition is this northwestern US based respiratory and home medical equipment provider, specializing in PAP and BiPAP therapy. This established Company has a solid reputation in the marketplace, strong contractual relationships and a diverse payor mix. This growing company serves its patients through multiple locations throughout the state. The growth plan for 2021 includes the opening of two additional locations in contiguous states.

A recent move into a new headquarters, a 11,000 sq. ft. location, provides warehouse, administrative and expanded patient care space. Additionally, with the new headquarters the company has developed their own resupply call center and centralized shipping. With the new facility, the company is well positioned for future growth and infrastructure capacity needs.  The Company’s staff include highly trained and experienced homecare professionals including licensed respiratory therapists and technicians.

In 2020, Company revenue exceed $7MM with adjusted EBITDA over $1.1MM. Revenue for the TTM period ending January 31, 2021 is $7.3M. The business is well positioned for continued organic growth and expanded geographic coverage.


For more information, please contact Paragon Ventures
Call: 800-719-1555 Ext. 205 or 603-661-7188 (cell)


AVAILABLE FOR ACQUISITION
PV ID#NE319-04025
Medical Supply - Cardiology Supply Manufacturer & Distributor

Revenue: $4.8MM - EBITDA: $775K
Cardiology focused Medical Supply Business with an extensive inventory of cardiology equipment and supplies selling to hospitals, medical offices and medical supply companies. In addition to supplying the most respected, major brands in cardiology, the Company is a manufacturer of custom kits for cardiology event recording and testing. The Company is a leading supplier for cardiology providers including echo/ultrasound, cardiac testing and monitoring equipment and supplies. The Company serves thousands of of medical professionals and their patients in the United States and globally.

For the trailing twelve months ending January 2021 the business generated $4.8MM and generated $775,000 EBITDA. The business is well positioned for continued growth and expansion. Additional information is available to qualified buyers.


For more information, 
Contact Tony Marsallo
Call: 800-719-1555, Ext 209 or (315) 559-3140 (mobile) 
Dollars & Sense on Valuations
Valuation has always been a pivotal factor in a business owner’s decision to sell. There are frequently additional motivating factors such as retirement, health, business opportunities, stress, and a variety of others, but they are usually coupled with an ability to obtain the right price and terms for the business.  

At no cost or obligation, we provide an analysis on the business that covers value and other market realities so you understand how much your business is worth in the current market.  We do this to help a business owner to make informed decisions before making any commitments to market and sell their business. Click here to read more of this article...
AVAILABLE FOR ACQUISITION
PV ID#PW320-60010
Medical Supply, Ostomy, Urological, Incontinence
Patient Care Products

Revenue: $5.6MM - EBITDA: $833K
Available for acquisition is a ostomy, urological, incontinence, patient care products and services provider with strong contract relationships and diverse payor mixes. The company provides the services and supplies to patients in their homes and at the company stores. The Company’s staff include highly trained and experienced homecare professionals including licensed prosthetic/orthotic fitters and technicians that serve the Companies growing patient population.

The Company’s long time market presence coupled with a favorable product mix drive strong margins and sustainable EBITDA. Over the trailing twelve months ended Dec 2020, the business has generated gross revenues of $ 5.67MM with an adjusted EBITDA of $ 833K. The Company continues to grow with solid contracts, referral relationships and a tremendous history of excellent service.


For more information, 
Contact Scott Fife
Call: 800-719-1555, Ext 203 or (215) 356-8003 (mobile) 
Note: Search Funds & Unfunded Sponsors:  Our clients will not process NDAs or accept offers from such groups until financial pre-qualifications are met. Proof of funds will be required before any letter of intent or offer to purchase will be considered from unfunded prospective buyers, i.e., independent sponsors, search funds, fund-less sponsors. An Earnest Deposit held in escrow may also be required.
2020 has been an exceptional and challenging year for everyone. Through it all, the M&A markets have rallied and continue to gain strength as we thankfully get beyond the pandemic and we look ahead to a better year in 2021. Below are a few of the transactions we have closed during COVID19 and we anticipate additional closings in the months ahead.


Transaction Closing

Paragon Ventures is pleased to announce the sale of NBN Infusions to The PromptCare Companies.


THE BUYER 
The PromptCare Companies provides infusion therapies, respiratory and medical supplies to patients.

THE SELLER 
NBN Infusions provides home infusion therapy involving the administration of medications using intravenous, subcutaneous and epidural routes.



If you would like more information about this transaction or Paragon Ventures contact Samantha Lincoln, Managing Director at 415-786-8153 or via email at slincoln@paragonventures.com

Transaction Closing

Paragon Ventures is pleased to announce the sale of its client, Respiratory Services of Western New York to AdaptHealth.

THE BUYER 
AdaptHealth is an national leader providing respiratory and medical supplies to patients throughout the UNited States.

THE SELLER 
Respiratory Services is a regional industry leader in respiratory and CPAP supplies.





If you would like more information about this transaction or Paragon Ventures contact Scott Fife, Managing Director at 215-356-8003 or via email at sfife@paragonventures.com

Transaction Closing

Paragon Ventures is pleased to announce the merger of its client, IMMUNOe Health Centers.


Our Client 
IMMUNOe Health Canters based in Colorado is an industry leader in biologic infusion therapies.











If you would like more information about this transaction or Paragon Ventures contact April H. Mason, Managing Director at (603)661-7188 or via email at amason@paragonventures.com

Transaction Closing

Paragon Ventures is pleased to announce the sale of its client, Absolute Respiratory Care to
Spiro Health.

THE BUYER 
Spiro Health (spirohealth.com) provides respiratory and medical supplies to patients throughout New England.

THE SELLER 
Absolute Respiratory Care based in Johnston, RI is an industry leader in respiratory and CPAP supplies.



If you would like more information about this transaction or Paragon Ventures contact April H. Mason, Managing Director at (603)661-7188 or via email at amason@paragonventures.com

Transaction Closing

Paragon Ventures is pleased to announce the sale of its client,
City Drugs to Biomatrix

THE BUYER 
BioMatrix Specialty Pharmacy offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions.

THE SELLER 
City Drugs (based in New York City is a highly accredited specialty pharmacy




If you would like more information about this transaction or Paragon Ventures contact Jonathan Sadock Managing Partner at 610-331-6900 or via email at jsadock@paragonventures.com

Transaction Closing

Paragon Ventures is pleased to announce the sale of its client, The Potter's House Child and Family Treatment Center to Refresh Mental Health.

THE BUYER 
Refresh Mental Refresh Mental Health owns and operates leading mental health practices with specialized programs throughout the United States

THE SELLER 
The Potter's House offers a continuum of care that moves our children, adolescents, and adults toward a more independent future.




If you would like more information about this transaction or Paragon Ventures contact April H. Mason, Managing Director at (603)661-7188 or via email at amason@paragonventures.com

Transaction Closing

Paragon Ventures is pleased to announce the sale of its client, PRO2 to OJ Medtech Charm Medical.

THE BUYER 
OJ Charm is a medical products company that provides a broad range of recurring need items such as compression garments, wound care supplies, incontinence products and nutritional products to customers throughout New England and New York.

THE SELLER 
PRO2 is a clinically oriented provider of home respiratory services, sleep therapy and related medical equipment and supplies.



If you would like more information about this transaction or Paragon Ventures contact Tony Marsallo, Managing Director at 315-559-3140 or via email at tmarsallo@paragonventures.com
The Strength of Healthcare M&A
Now and On The Horizon
What is driving all the M&A activities for privately held healthcare businesses through a global pandemic and beyond?

  • Is it Availability of Capital?
  • Is it Uncertainty of Rising Taxes?
  • Is it the possibility of Higher Interest Rates?

This PWC article link and the slides below show the power of the current financial and debt markets driving buyer/investor M&A appetites. The amount of available capital in 2020 for mergers & acquisitions is unprecedented. This year the USA funding and stimulus spending amid the pandemic has been equally historic. While the results of the election may be uncertain, experts agree that there will be tax increases in the years ahead… no matter who wins the election. Future tax impacts could be egregious for capital gains and estate taxes as well. A similar uncertainty exists with interest rates which already are at historically low levels. With all of these factors, it is easy to understand how the M&A markets are being propelled and buyer/investor interests are growing.

For healthcare business owners, the growth and consolidation which has been increasing over the past few years, is accelerating. Corporate buyers and strategic private equity continue to seek strong, growing healthcare businesses and their appetites are increasing. It should also be noted that the buyer profiles have also changed with cross-modality and deep reaching synergies also driving opportunities.

Consolidation of healthcare services will also continue to improve outcomes and economic performance will be enhanced as we shift patient volumes to less costly care sites, and leverage technology across the continuum of care.

Exploring Strategic Options
There are many options to consider as the ultimate goal for the many years of hard work building and growing your company. For mature and profitable healthcare businesses today there are many strategic options to consider. These options include acquisitions, merger, divestiture, and recapitalization. Each of these options requires careful consideration to determine what is the best fit for the stakeholder’s goals for the business.

Should you consider a buyer or an investor? If your goal is to sell and ride off into the sunset, then your focus should be on a divestiture. If your interest is in taking chips off the table while continuing to grow the business over the next three to five years, then a recapitalization may be the best path for you. Each option has differing effects on valuation, the process and the pathway to a successful closing.
Exit strategy planning is one of the most overlooked – and most important aspects – of a business owner’s dream. You would not read all but the last chapter of a book… nor should you ignore the final chapter in your business ownership.  Contact us today to discuss your strategic options.


We are wrapping up some new opportunities which will soon be available in market



The Paragon Ventures Private Client Group M&A Team
800-719-1555